Article info

Download PDFPDF

A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma

Authors

  • Yiyin Zhang Department of Pancreatic SurgeryFudan University Shanghai Cancer Center Shanghai China Department of Oncology Shanghai Medical CollegeFudan University Shanghai China Pancreatic Cancer InstituteFudan University Shanghai China Shanghai Pancreatic Cancer Institute Shanghai China PubMed articlesGoogle scholar articles
  • Jin Xu Department of Pancreatic SurgeryFudan University Shanghai Cancer Center Shanghai China Department of Oncology Shanghai Medical CollegeFudan University Shanghai China Pancreatic Cancer InstituteFudan University Shanghai China Shanghai Pancreatic Cancer Institute Shanghai China PubMed articlesGoogle scholar articles
  • Jie Hua Department of Pancreatic SurgeryFudan University Shanghai Cancer Center Shanghai China Department of Oncology Shanghai Medical CollegeFudan University Shanghai China Pancreatic Cancer InstituteFudan University Shanghai China Shanghai Pancreatic Cancer Institute Shanghai China PubMed articlesGoogle scholar articles
  • Jiang Liu Department of Pancreatic SurgeryFudan University Shanghai Cancer Center Shanghai China Department of Oncology Shanghai Medical CollegeFudan University Shanghai China Pancreatic Cancer InstituteFudan University Shanghai China Shanghai Pancreatic Cancer Institute Shanghai China PubMed articlesGoogle scholar articles
  • Chen Liang Department of Pancreatic SurgeryFudan University Shanghai Cancer Center Shanghai China Department of Oncology Shanghai Medical CollegeFudan University Shanghai China Pancreatic Cancer InstituteFudan University Shanghai China Shanghai Pancreatic Cancer Institute Shanghai China PubMed articlesGoogle scholar articles
  • Qingcai Meng Department of Pancreatic SurgeryFudan University Shanghai Cancer Center Shanghai China Department of Oncology Shanghai Medical CollegeFudan University Shanghai China Pancreatic Cancer InstituteFudan University Shanghai China Shanghai Pancreatic Cancer Institute Shanghai China PubMed articlesGoogle scholar articles
  • Miaoyan Wei Department of Pancreatic SurgeryFudan University Shanghai Cancer Center Shanghai China Department of Oncology Shanghai Medical CollegeFudan University Shanghai China Pancreatic Cancer InstituteFudan University Shanghai China Shanghai Pancreatic Cancer Institute Shanghai China PubMed articlesGoogle scholar articles
  • Bo Zhang Department of Pancreatic SurgeryFudan University Shanghai Cancer Center Shanghai China Department of Oncology Shanghai Medical CollegeFudan University Shanghai China Pancreatic Cancer InstituteFudan University Shanghai China Shanghai Pancreatic Cancer Institute Shanghai China PubMed articlesGoogle scholar articles
  • Xianjun Yu Department of Pancreatic SurgeryFudan University Shanghai Cancer Center Shanghai China Department of Oncology Shanghai Medical CollegeFudan University Shanghai China Pancreatic Cancer InstituteFudan University Shanghai China Shanghai Pancreatic Cancer Institute Shanghai China PubMed articlesGoogle scholar articles
  • Si Shi Department of Pancreatic SurgeryFudan University Shanghai Cancer Center Shanghai China Department of Oncology Shanghai Medical CollegeFudan University Shanghai China Pancreatic Cancer InstituteFudan University Shanghai China Shanghai Pancreatic Cancer Institute Shanghai China PubMed articlesGoogle scholar articles

Citation

Zhang Y, Xu J, Hua J, et al
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.